| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 221-228, Copyright © 1992 by Endocrine Society
ARTICLES |
M Komatsu, T Aizawa, N Yokokawa, Y Sato, N Okada, N Takasu and T Yamada
Department of Geriatrics, Shinshu University School of Medicine, Nagano- ken, Japan.
Mastoparan, a tetradecapeptide purified from wasp venom, stimulates insulin and glucagon release by rat pancreatic islets in a dose-related manner. In perifusion experiments, mastoparan produces monophasic hormone release, which ceases within 10 min of removal of the peptide. After exposure of the isles to mastoparan, glucose-induced insulin release is clearly retained. In incubation experiments, mastoparan- induced insulin release is greatly blocked by pretreatment of the islets with pertussis toxin or neomycin (inhibitor of phosphoinositide turnover) or by lowering the ambient temperature to 17 C. Pretreatment of the islets with nifedipine (calcium channel blocker), H-7 (inhibitor of A- and C-kinase), somatostatin, or divalent cation-free medium does not affect the response to mastoparan. Pretreatment with parabromophenacylbromide (phospholipase-A2 inhibitor) does not block the response induced by a high concentration of (58 microM) mastoparan. The peptide does not stimulate insulin synthesis during 30 min of incubation. Mastoparan raises the cytosolic free Ca2+ concentration, measured by fura-2, in isolated islet cells at normal (1.9 mM) and very low (6.5 microM) extracellular Ca2+ concentrations. Intravenous administration of mastoparan in rats causes a significant elevation of both insulin and glucagon. Together with the previous data, we conclude that mastoparan stimulates islet hormone release through a temperature- dependent process mediated by pertussis toxin-sensitive GTP-binding protein(s). Activation of phospholipase-C and liberation of intracellular Ca2+ are likely to be coupled to exocytosis. Ca2+ influx through the Ca2+ channel and protein kinase-A and -C appear not to be involved in mastoparan's hormone-releasing action. Phospholipase-A2 may be involved in the hormone release induced by low, but not high, concentrations of the peptide.
This article has been cited by other articles:
![]() |
A. Kowluru Regulatory roles for small G proteins in the pancreatic {beta}-cell: lessons from models of impaired insulin secretion Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E669 - E684. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Amin, H.-Q. Chen, R. Veluthakal, R. B. Silver, J. Li, G. Li, and A. Kowluru Mastoparan-Induced Insulin Secretion from Insulin-Secreting {beta}TC3 and INS-1 Cells: Evidence for Its Regulation by Rho Subfamily of G Proteins Endocrinology, October 1, 2003; 144(10): 4508 - 4518. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakazaki, A. Crane, M. Hu, V. Seghers, S. Ullrich, L. Aguilar-Bryan, and J. Bryan cAMP-Activated Protein Kinase-Independent Potentiation of Insulin Secretion by cAMP Is Impaired in SUR1 Null Islets Diabetes, December 1, 2002; 51(12): 3440 - 3449. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Seghers, M. Nakazaki, F. DeMayo, L. Aguilar-Bryan, and J. Bryan Sur1 Knockout Mice. A MODEL FOR KATP CHANNEL-INDEPENDENT REGULATION OF INSULIN SECRETION J. Biol. Chem., March 24, 2000; 275(13): 9270 - 9277. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Jones and S. J. Persaud Protein Kinases, Protein Phosphorylation, and the Regulation of Insulin Secretion from Pancreatic {beta}-Cells. Endocr. Rev., August 1, 1998; 19(4): 429 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Komatsu, M. Noda, and G. W. G. Sharp Nutrient Augmentation of Ca2+-Dependent and Ca2+-Independent Pathways in Stimulus-Coupling to Insulin Secretion Can Be Distinguished by Their Guanosine Triphosphate Requirements: Studies on Rat Pancreatic Islets Endocrinology, March 1, 1998; 139(3): 1172 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-G. Ostenson, S. Zaitsev, P.-O. Berggren, S. Efendic, U. Langel, and T. Bartfai Galparan: A Powerful Insulin-Releasing Chimeric Peptide Acting at a Novel Site Endocrinology, August 1, 1997; 138(8): 3308 - 3313. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yajima, K. Uchino, H. Ito, and S. Kawashima Mastoparan-Stimulated Prolactin Secretion in Rat Pituitary GH3 Cells Involves Activation of Gq/11 Proteins Endocrinology, May 1, 1997; 138(5): 1949 - 1958. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suzuki, T. Aizawa, N. Asanuma, Y. Sato, M. Komatsu, H. Hidaka, N. Itoh, K. Yamauchi, and K. Hashizume An Early Insulin Intervention Accelerates Pancreatic {beta}-Cell Dysfunction in Young Goto-Kakizaki Rats, a Model of Naturally Occurring Noninsulin-Dependent Diabetes Endocrinology, March 1, 1997; 138(3): 1106 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Asanuma, T. Aizawa, Y. Sato, T. Schermerhorn, M. Komatsu, G. W. G. Sharp, and K. Hashizume Two Signaling Pathways, from the Upper Glycolytic Flux and from the Mitochondria, Converge to Potentiate Insulin Release Endocrinology, February 1, 1997; 138(2): 751 - 755. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |